Table 2.

Differences in Blood Pressure Categorization and Definition of Cardiac Target Organ Damage by Different Pediatric Guidelines

Cardiovascular Disease Risk Factor	Fourth Report (2004)	AAP Clinical Practice Guideline (2017)		ESH Guidelines (2016)
	All Children	<13 years	≥ 13 years	<16 years	≥ 16 years
Normotension	<90^th %ile	<90^th %ile^*	<120/80	<90^th %ile	<130/85
Prehypertension/Elevated Blood Pressure	≥90^th %ile^* to <95^th %ile	≥90^th %ile^* to <95^th %ile	120-129/<80	≥90^th %ile^* to <95^th %ile	130-139/85-90
Stage 1 Hypertension	≥95^th to ≤ 99^th + 5 mmHg	≥95^th to < 95^th + 12 mmHg^¥	130-139/80-89	≥95^th to ≤ 99^th + 5 mmHg	140-159/90-99
Stage 2 Hypertension	>99^th + 5 mmHg	≥95^th + 12 mmHg^€	≥ 140/90	>99^th + 5 mmHg	160-179/100-109
Left Ventricular Hypertrophy	LVMI > 51 g/m^2.7^£	LVMI > 51 g/m^2.7^β or LVM > 115 g/BSA for boys and LV mass >95 g/BSA for girls		LVMI > age-sex specific 95^th %ile
Increased Relative Wall Thickness	Not defined	>0.42		>0.38

Or 120/80, whichever lower;

^¥

Or 130/80-139-89, whichever lower;

^€

Or ≥ 140/90, whichever lower

^£

“conservative cutpoint”

^β

For children >8 years

AAP: American Academy of Pediatrics; BSA: body surface area; ESH: European Society of Hypertension; LVM: left ventricular mass; LVMI: left ventricular mass index

Fourth Report: National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-76